The WACC of BioMark Diagnostics Inc (BUX.CN) is 5.3%.
Range | Selected | |
Cost of equity | 4.60% - 6.20% | 5.40% |
Tax rate | 25.90% - 26.50% | 26.20% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 4.5% - 6.1% | 5.3% |
Category | Low | High |
Long-term bond rate | 3.2% | 3.7% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.28 | 0.33 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 4.60% | 6.20% |
Tax rate | 25.90% | 26.50% |
Debt/Equity ratio | 0.04 | 0.04 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 4.5% | 6.1% |
Selected WACC | 5.3% | |